Related Experiment Video
Updated: Jul 15, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus
Andrea Jansen1, Michael Türck, Christiane Szekat
1Institut für Medizinische Mikrobiologie, Immunologie und Parasitologie, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany.
Abstract:
The glycopeptide antibiotic vancomycin acts by binding to the D-alanyl-D-alanine terminus of the cell wall precursor lipid II in the cytoplasmic membrane. The purpose of this study was the identification of genes that might be involved in the vancomycin resistance mechanism. To this end, the expression profiles of two vancomycin intermediately resistant Staphylococcus aureus (VISA) strains, the clinical isolate S. aureus SA137/93A (Etest: 8 microg/ml) and its laboratory mutant S. aureus SA137/93G (Etest: 12 microg/ml) were analyzed using an S. aureus full-genome chip. The results indicated that an essential two-component regulatory system, yycF (vicR) and yycG (vicK) was drastically up-regulated in strain SA137/93A. Sequencing of the yycFG promoter region of strain SA137/93A revealed an insertion of IS256 in the predicted promoter region creating a potentially stronger hybrid promoter. In strain SA137/93G, IS256 was not integrated in the yycFG promoter region but, in previous studies, a copy of IS256 had been found to inactivate the tcaA gene (Maki et al. Antimicrob. Agents and Chemother. 48, 1953-1959 (2004)). Detailed population analyses showed that, in addition to the loss of SCCmec, the inactivation of tcaA seems to cause at least part of the increase in teicoplanin and vancomycin resistance in strain SA137/93G.
Insights
Vancomycin resistance in Staphylococcus aureus involves the upregulation of the yycFG regulatory system and IS256 insertions. These genetic changes contribute to increased resistance in vancomycin-intermediate resistant S. aureus (VISA) strains.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Vancomycin is a critical glycopeptide antibiotic targeting bacterial cell wall synthesis.
- Understanding vancomycin resistance mechanisms in Staphylococcus aureus is crucial for effective treatment.
- Vancomycin intermediate-resistant Staphylococcus aureus (VISA) poses a significant clinical challenge.
Purpose of the Study:
- To identify genes involved in vancomycin resistance in Staphylococcus aureus.
- To analyze the expression profiles of vancomycin-resistant strains.
- To investigate the role of genetic elements like IS256 in resistance.
Main Methods:
- Gene expression profiling using a Staphylococcus aureus full-genome chip.
- Sequencing of the yycFG promoter region.
- Analysis of IS256 insertion and gene inactivation.
- Population analyses of resistant strains.
Main Results:
- The yycF (vicR) and yycG (vicK) two-component regulatory system was significantly upregulated in a VISA strain (SA137/93A).
- An IS256 insertion in the yycFG promoter region of SA137/93A created a potentially stronger hybrid promoter.
- In another VISA strain (SA137/93G), IS256 was found to inactivate the tcaA gene, contributing to increased resistance.
Conclusions:
- The yycFG regulatory system plays a role in vancomycin resistance in S. aureus.
- IS256 insertions, either in promoter regions or leading to gene inactivation (e.g., tcaA), are key mechanisms contributing to vancomycin and teicoplanin resistance.
- Loss of SCCmec and tcaA inactivation contribute to increased resistance in VISA strains.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Antibiotic Selection
Regulation of Bacterial Virulence
Staphylococcal Skin Infections